2Li JS, Berezny K, Kilaru R, et al. Is the extrapolated adult dose of fosinopril safe and effective in treating hypertensive children? Hypertension ,2004,44( 3 ) :289-293.
3Nakanishi K, Iijima K, Ishikura K, et al. Efficacy and safety of lisinopril for mild childhood IgA nephropathy: a pilot study. Pediatr Nephrol, 2009,24(4) :845-849.
4Fogo AB. Mechanisms of progression of chronic kidney disease. Pediatr Nephro1,2007,22 ( 12 ) :2011-2022.
5Zanabli AR, Yango A, Dworkin L. Incidence of hyperkalemia in high risk patients during treatment with an angiotensin converting enzyme inhibitor (Lisinopril) versus an angiotensin II receptor blocker (Losartan). S D J Med, 2004,57 (6) : 227- 231.
6Vegter S, de Jong-van den Berg LT. Misdiagnosis and mistreatment of a common side-effect-angiotensin-eonverting enzyme inhibitor-induced cough. BrJ Clin Pharmacol, 2010,69 (2) :200-203.
7Yi Z, Li Z, Wu XC, et al. Effect of fosinopril in children with teroid-resistant idiopathic nephrotic syndrome. Pediatr Nephrol, 2007,21 (7) :967-972.
8Lind T, Lonnerdal B, Stenlund H, et al. A community-based randomized controlled trim of iron and zinc supplementation in Indonesian infants: effects on growth and development. Am J Clin Nutr, 2004,80(3 ) :729-736.
9Seeman T, Dusek J, Vondrdk K, et al. Ramipril in the treatment of proteinuria in children after renal transplantation. Pediatr Transplant, 2010,14 ( 2 ) : 283 -287.
10Morrone LF, Di Paolo S, Logoluso F, et al. Interference of angiotensin-converting enzyme inhibitors on erythropoiesis in kidney transplant recipients: role of growth factors and cytokines. Transplantation, 1997,64 ( 6 ) : 913-918.
